Nutrient History

What Is Impulsin? The Original 1970s Name for PEA

By Dr. Meredith Warner, MD, board-certified orthopedic surgeon. Reviewed September 29, 2026.

Impulsin is the original pharmacy brand name for palmitoylethanolamide, usually shortened to PEA, a fatty acid amide the human body produces on its own. The name first appeared on Czechoslovak pharmacy shelves in the early 1970s, decades before PEA became a familiar sight on American supplement labels.

That history is more than trivia. It means PEA was studied as a pharmacy-grade preparation long before the modern supplement era, and the molecule inside those original packets is chemically identical to the PEA sold today. Few everyday nutrients can claim a fifty-year paper trail that starts behind a pharmacist’s counter.

Today the same molecule is available as a single-ingredient supplement, including The Well Theory’s focused PEA capsule, which lists 550 mg of palmitoylethanolamide per serving and nothing else.

Key Takeaways

Impulsin is PEA. Impulsin was the brand name under which palmitoylethanolamide was sold in 1970s Czechoslovakia, and the molecule itself is unchanged today.
The body makes its own supply. PEA is a fatty acid amide produced naturally within human tissues as part of how the body manages its own inflammatory signaling.
Mast cells are the classic target. Research on PEA has long centered on how it influences mast cells, the immune cells that release histamine and other signaling compounds.
The paper trail is long. PEA has been examined in laboratory studies and controlled human research spanning five decades, summarized in recent systematic reviews.
A modern single-ingredient option exists. PEA (Palmitoylethanolamide) Joint Comfort + Inflammatory Balance lists 550 mg of PEA per vegan capsule to support joint comfort and a healthy inflammatory response.

Impulsin: the original pharmaceutical brand name for palmitoylethanolamide (PEA), a fatty acid amide introduced in Czechoslovakia in 1970 by the manufacturer Spofa and later withdrawn from the drug market; the same molecule is now sold as a dietary supplement.

What Is Impulsin?

The short answer is that Impulsin is a name, not a different molecule. In 1970, the Czechoslovak manufacturer Spofa introduced palmitoylethanolamide under the brand name Impulsin, and it was dispensed as a pharmacy product for everyday seasonal use. The product came and went from pharmacy shelves over the following years, but the research it generated kept accumulating long after the name faded.

One molecule, two eras. The compound sold as Impulsin in the 1970s is chemically the same palmitoylethanolamide found in supplement capsules today.
The research survived the brand. Czech and Slovak laboratories published studies on Impulsin through the 1970s, including work on how it influenced innate immune defenses in animal models.
The regulatory category changed, not the chemistry. PEA moved from a pharmacy product in one country to a dietary supplement ingredient in many, which changed how it can be described rather than what it is.

Impulsin is best understood today as the historical proof that PEA was taken seriously as a preparation long before the supplement industry discovered it.

How Does PEA Work in the Body?

PEA belongs to a family of fat-like compounds the body manufactures on demand within its own tissues. Reviews of PEA research describe it as part of the body’s built-in machinery for keeping inflammatory signaling within normal bounds, which is why researchers sometimes call it a locally produced autacoid rather than a nutrient that must come from food.

It is made where it is used. Unlike a vitamin that must arrive from the diet, PEA is synthesized inside tissues as part of the normal response to everyday physical stress.
Mast cells are the classic focus. Much of the original Impulsin-era research and modern laboratory work alike has examined how PEA influences mast cells, the immune cells that release histamine and other compounds when they are activated.
The entourage connection. PEA also interacts with the body’s own endocannabinoid signaling, a relationship we explain in our piece on PEA and the entourage effect.
Food supplies only traces. Small amounts appear in foods such as egg yolks and soybeans, but the quantities found in research preparations are far higher than a plate provides, which is why capsule forms exist.

PEA is one of the few supplement ingredients the body has been manufacturing for itself since before anyone thought to bottle it.

A Pharmacy Product Before It Was a Supplement

The Impulsin story begins in a specific place and time: communist-era Czechoslovakia, where the state pharmaceutical industry took an interest in compounds that could support everyday wellness through the winter months. Spofa brought Impulsin to market in 1970, and researchers in Bratislava and beyond spent years studying its effects, including its influence on innate immune defenses in laboratory animals.

1970: the launch. Impulsin appeared on Czechoslovak pharmacy shelves as a palmitoylethanolamide preparation intended for seasonal everyday use.
1970s: the research program. Published studies from the period examined interferon production and antiviral resistance in animals treated with the compound, work that anchored decades of later research.
Withdrawal, then rebirth. The product was later withdrawn from the drug market, but by the 1990s and 2000s PEA had returned as a dietary supplement ingredient, now studied in controlled human trials across Europe and beyond.

A molecule introduced behind a pharmacy counter in 1970 is now one of the most reviewed compounds in the joint-comfort category.

Why Fifty Years of Research Still Matters

Longevity in the literature is rare in the supplement aisle, where most ingredients enjoy a few exciting years and then fade. PEA’s record is different in both depth and kind: laboratory work from the 1970s was followed by decades of laboratory and clinical study, and recent systematic reviews have gathered the double-blind randomized trials into one place for anyone to examine.

The reviews are public. A 2023 systematic review and meta-analysis in the journal Nutrients compiled the double-blind randomized controlled trials of PEA, an unusually deep evidence base for a supplement ingredient.
Tolerability has been part of the record. Across that literature, PEA has generally been described as well tolerated, with occasional mild digestive complaints reported in some individuals.
The mechanism is documented, not invented. Unlike ingredients pitched on folklore, PEA’s mast-cell research predates most of today’s supplement marketing by half a century.

An ingredient with fifty years of published research asks for consistency, not blind faith.

What the History Means for a Daily Routine

For someone assembling a joint-comfort routine, the Impulsin story carries a practical lesson: choose the form that states its dose plainly. That is the philosophy behind the capsule below.

PEA (Palmitoylethanolamide) Joint Comfort + Inflammatory Balance is a single-ingredient formula that lists 550 mg of palmitoylethanolamide per vegan capsule, with no botanical blends and no fillers sharing the serving, to support joint comfort and the body’s normal inflammatory response.

One ingredient, stated plainly. The label lists 550 mg of PEA and nothing else, which echoes the pharmacy-era practice of naming the compound and the amount.
A capsule for consistency. Thirty capsules per bottle, one per day, taken with the understanding that this category of ingredient is studied over weeks and months of steady use rather than overnight.
Formulated by a surgeon. The formula was developed under the guidance of a board-certified orthopedic surgeon who has spent decades around joints, as we describe in our introduction to what PEA is and where it comes from.

Bottle of The Well Theory PEA palmitoylethanolamide capsules with capsules beside it — PEA (Palmitoylethanolamide) Joint Comfort + Inflammatory Balance: 550 mg single-ingredient PEA per capsule.

Is PEA Safe for Everyday Use?

The honest answer from five decades of literature is encouraging but bounded. PEA has generally been described as well tolerated in published research, with occasional reports of mild digestive discomfort in some individuals. The long-term record beyond several months of continuous use, and the picture during pregnancy or nursing, are areas where the reliable information is still limited, so those decisions belong with a clinician.

Well tolerated in studies to date. Systematic reviews of the controlled trials report a tolerability profile that compares favorably with many everyday compounds.
Mild digestive complaints can occur. The most commonly noted complaint in available information is occasional nausea in some people, which often resolves with food.
Ask about the edge cases. Anyone pregnant, nursing, taking medication, or managing a health condition should discuss a new supplement with a qualified healthcare professional first.

A fifty-year-old molecule deserves the same caution any new addition to a routine does: start, observe, and give it time.

The Bottom Line

Impulsin is not a new ingredient wearing a vintage name; it is the original name for a molecule the body already makes, sold as a pharmacy product in 1970 and reborn as a modern supplement ingredient.

Know the alias. Impulsin, palmidrol, and palmitoylethanolamide all describe the same fatty acid amide.
Respect the mechanism. Decades of research tie PEA to the body’s management of its own inflammatory signaling, with mast cells as the classic focus.
Choose a stated dose. PEA (Palmitoylethanolamide) Joint Comfort + Inflammatory Balance lists 550 mg of PEA per capsule and nothing else, to support joint comfort and a healthy inflammatory response.
Give it ninety days. The research tradition around PEA is about steady, consistent use, not overnight change.

The newest thing about PEA is the label it wears; the molecule itself has been on file since 1970.

Frequently Asked Questions

What is Impulsin?

Impulsin is the brand name under which palmitoylethanolamide (PEA) was sold in Czechoslovakia starting in 1970. The product was later withdrawn from the drug market, and the same molecule is now available as a dietary supplement ingredient.

Is Impulsin the same as PEA?

Yes. Impulsin was a brand name, and the active compound was palmitoylethanolamide, the same fatty acid amide the body produces within its own tissues and the same molecule found in modern PEA supplements.

What does PEA do in the body?

PEA is produced naturally in human tissues and has been studied for how it influences mast cells and the body’s own inflammatory signaling. Supplement labels describe it as supporting joint comfort and a healthy inflammatory response.

Is PEA safe to take every day?

Published research generally describes PEA as well tolerated, with occasional mild digestive complaints in some individuals. Information on use beyond a few months, and during pregnancy or nursing, remains limited, so those cases call for a conversation with a clinician.

How long does PEA take to work?

Research in this category frames PEA as an ingredient studied over weeks and months of consistent daily use rather than a fast-acting compound. Dr. Warner’s standard advice is to give any new supplement a full ninety days before judging it.